Hos FAP- patienter med moderat nedsat leverfunktion (serum - albumin 25- 35 g/ l) bør den daglige anbefalede dosis af celecoxib reduceres med 50%.
In FAP patients with moderate hepatic impairment (serum albumin of 25-35 g/ l), the daily recommended dose of celecoxib should be reduced by 50%.